Programming T Cells for Successful Adoptive Cell Therapy
Programming T Cells for Successful Adoptive Cell Therapy
批准号:
8782916
负责人:
Claudia Marcela Diaz-Montero
金额:
$13.06万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-18 至 2015-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long term goal of this career development award is to establish the candidate, Dr. C. Marcela Diaz-Montero, as an independent translational scientist. To achieve this goal, the candidate, concurrently with her mentors, has designed a comprehensive training plan that includes research and extramural funding mentoring, as well as an educational component on the design, implementation and conduct of clinical trials. The candidate's research interests focus on enhancing the activity of T lymphocytes for adoptive cell therapy. She has made the novel observation that antigen-dependent activation of CD8+ T cells in the presence of IL-12 results in the accumulation of a subpopulation of T cells with an early-activated phenotype (TEA). In vivo, TEA show augmented survival and increased anti-tumor activity. Based on these observations, it is hypothesized that TEA have an enhanced ability to reach secondary lymphoid organs; and that their immature phenotype allows them to progress through the activation process under optimal stimulatory conditions resulting in effector cells with stronger anti-tumor capabilities and superior immunologic memory. To test this hypothesis the following specific aims are being proposed: 1) Define the contribution of homing to the lymph node to the survival and maturation of transferred TEA; 2) Ascertain if enhanced survival of TEA is due to their plasticity conferring a competitive advantage for cytokine sinks; 3) Determine the impact of enhanced TEA on the generation of T cell memory; 4) Test the impact of activation in the presence of IL-12 on the phenotypic and functional characteristics of human TCR transduced T cells. A better understanding of the programming and differentiation of CD8+ T cells will allow us to identify the subset best fitted for ACT therapy for cancer and to design effective strategies that enhance the generation and survival of this subset. In addition, these studies represent the foundation for the candidate's research program that through close mentorship will develop into a state of the art, extramurally funded program in cancer immunotherapy. The mentors, Dr. Joseph Rosenblatt and Dr. Eli Gilboa, are experts in the field of cancer immunology and adoptive cell therapy with extensive mentorship experience. In addition, the University of Miami has made a significant investment in the candidate, which reflects on her potential to achieve her proposed goals. Dr. Diaz-Montero was recruited as part of the Dodson Interdisciplinary Immunotherapy Institute initiative to develop high-impact and broadly useful immune-based treatments. Her recruitment package included start up funds and laboratory space. In summary, this award will provide the candidate protective time to conduct her proposed studies and to fully exploit the outstanding institutional environment available at the University of Miami with the ultimate goal of becoming a successful translational scientist in cancer immunotherapy.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1186/1479-5876-11-62
发表时间:
2013-03-08
期刊:
Journal of translational medicine
影响因子:
7.4
作者:
[Diaz CM, Chiappori A, Aurisicchio L, Bagchi A, Clark J, Dubey S, Fridman A, Fabregas JC, Marshall J, Scarselli E, La Monica N, Ciliberto G, Montero AJ]
通讯作者:
Montero AJ
DOI:
10.1158/1078-0432.ccr-15-1823
发表时间:
2017-05-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Najjar YG, Rayman P, Jia X, Pavicic PG Jr, Rini BI, Tannenbaum C, Ko J, Haywood S, Cohen P, Hamilton T, Diaz-Montero CM, Finke J]
通讯作者:
Finke J
Mechanisms of cancer immunotherapy-associated thrombosis
-
批准号:10667046
-
项目类别:
-
资助金额:$72.14万
-
财政年份:2023
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Translational and Clinical Trial Correlates Core
-
批准号:10526306
-
项目类别:
-
资助金额:$45.44万
-
财政年份:2022
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Translational and Clinical Trial Correlates Core
-
批准号:10704716
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2022
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:7934010
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8305696
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8531675
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:8133731
-
项目类别:
-
资助金额:$13.06万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
Programming T Cells for Successful Adoptive Cell Therapy
-
批准号:7741444
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2009
-
负责人:Claudia Marcela Diaz-Montero
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: